Ampio Class Action Lawsuit AMPE | Deadline October 17, 2022

Great news! The AMPE Lawsuit has been filed, and investors who purchased Ampio Class Action Lawsuit (Ampio Pharmaceuticals) shares between March 10, 2022, and December 6, 2022, are eligible to take part.

TO LEARN MORE ABOUT THE AMPE CLASS ACTION LAWSUIT, CLICK HERE

According to the AMPE lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that:

(i) that the number of virtual visits clients were undertaking utilizing LifeStance Health was decreasing as the COVID-19 lockdowns were being lifted, thereby flatlining LifeStance Health’s out-patient/virtual revenue growth;

(ii) that the percentage of in-person visits clients were undertaking utilizing LifeStance Health was increasing as the COVID-19 lockdowns were being lifted, thereby causing LifeStance Health’s operating expenses to increase substantially;

(iii) that LifeStance Health had lost a large number of physicians due to burn-out and, as a result, its physician retention rate had fallen significantly below the 87% highlighted in the IPO’s registration statement and LifeStance Health had been expending additional costs to onboard new physicians who were less productive than the outgoing physicians they were replacing; and

(iv) as a result, LifeStance Health’s business metrics and financial prospects were not as strong as the IPO’s registration statement represented.

If you suffered a loss in AMPE you have until October 17, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.